Notably, overexpression of SPON2 in LS174T and DLD1 CRC cell lines demonstrated an inhibitory effect on cell proliferation, whereas removal of SPON2 using short interfering RNA (siRNA) led to a significant enhancement in cell proliferation for both cell lines. Here, SPON2 is linked to colorectal carcinoma.